(CNN) — The US Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as anaphylaxis, providing a needle-free alternative to EpiPens and ...
NEW YORK (Reuters Health) - The "second generation" allergy drug desloratadine (brand name Clarinex) significantly reduces both the runny nose and congestion of seasonal and persistent allergic ...
Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. ON THIS PAGE If you've ever dealt with sinus ...
The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts who reviewed the latest research on ...
The first non-injectable emergency treatment for allergies is anticipated to hit shelves following FDA approval of the neffy epinephrine nasal spray. The product from ARS Pharmaceuticals, previously ...
Seasonal allergies are worsening due to climate change. Learn how to manage symptoms, choose the right medications, and when ...
On 9 August, US health officials approved the first nasal spray to treat allergic reactions from drugmaker ARS Pharmaceuticals Inc, an alternative to injectable allergy medications like EpiPen. The ...
If you, your child or a loved one are managing a life-threatening allergy, then you know what it’s like to have an EpiPen or Auvi-Q stashed in every bag to ward off anaphylaxis. The injectable ...
ST. LOUIS — The FDA said a common ingredient found in many cold and allergy medications is not effective. It's called phenylephrine and claims to help with congestion. For more than 15 years, the drug ...
(AP) - U.S. health officials on Friday approved a nasal spray to treat severe allergic reactions, the first needle-free alternative to shots like EpiPen. The Food and Drug Administration said it ...
According to the latest market analysis by Future Market Insights, the global nasal sprays market is poised for consistent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results